At the VII Congress of Anesthesiologists and Intensivists of Kazakhstan held in Turkestan from April 26-27, 2024, Amoul showcased its innovative lifesaving solutions. The Congress was attended by leading scientists and specialists of practical healthcare in Kazakhstan and neighboring countries, and it drew a lot of attention from critical care professionals. It was a significant forum for leading experts in the field of anesthesiology and resuscitation.

Representatives from the South Kazakhstan Medical Academy, including Professor Aldeshev Almas Aldeshevich and his team of assistants and residents, attended the congress. Professor Zhumadilov Agzam Shaimardanovich, Chairman of the Kazakh Society of Anesthesiologists and Intensivists, delivered a welcoming speech and extended his congratulations to Professor A.A. Aldeshev on his 75th birthday. In his congratulatory speech, he expressed his gratitude, on behalf of the society, for Professor Aldeshev's contributions to medical science and education, as well as his expertise in the field of anesthesiology and intensive care. Professor Aldeshev, in turn, expressed his appreciation for the attention and well wishes and wished everyone present success and dedication in their work.

During the congress, Amoul® CABD total solutions were presented, which included T7, CPR E6, and AED i3, AM-5. These innovative medical devices have already proven their reliability and efficiency in the global market. All of them are dependable lifesaving solutions that can be used in high-pressure situations, like helicopter transport or high-altitude emergencies.

The CPR E6 uses cutting-edge technology to improve the standard of CPR during the resuscitation process. The AED i3 uses proven defibrillation technology to accurately analyze heart rhythms and provide effective CPR guidance and rescue shock to restore the cardiac arrest victims' hearts. Truly, these are lifesaving devices.

The professional moderator of the cardiac resuscitation section was the head of the Department of Anesthesiology and Intensive Care at the NAO Shymkent Heart Center. The Congress allowed for the discussion of the possibilities of providing a wide range of medical services through the introduction of advanced medical technologies and internationally recognized standards of quality and safety of medical care for children and adult patients. We would like to thank all the participants who made it possible and our partner, TND Medical Technologies, for their invaluable support in promoting our advanced life support innovations to improve pre-hospital care and post-hospital outcomes for all Kazakh patients.

At Amoul, we take pride in our mission to develop emergency and intensive care solutions that help save lives. As part of this mission, we are constantly striving to upgrade our life support technology to ensure that it is always at the forefront of medical advancements. We are committed to spreading our knowledge and expertise worldwide, so that as many people as possible can benefit from the latest life-saving solutions.